Trill Impact Ventures
Venture capital
RollingLast verified 10 Nov 2026
Impact-focused venture capital strategy investing in early-stage green tech and life science startups across Europe and North America.
2 deals in the last 24 months, latest 3 Nov 2026. Derived from its deals in the news.
Key facts
- Stages
- Series A, Series C+
- Sectors
- Cleantech, Biotech & pharma
- Eligible countries
- Not stated
- Provider based in
- Sweden
- Timing
- Rolling applications
- Focus
- Green Tech; Life Science
- How to apply
- Apply route unknown
- Source
- https://trillimpact.com/
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| Zafrens | Series A | Biotech & pharma, AI & machine learning | €5.3M | lead | 3 Nov 2026 |
| Open Cosmos | Series C+ | Space, Hardware & IoT | €300M | lead | 28 Sep 2026 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
Ventures Minority investments in early-stage companies in Europe and North America, primarily in Green Tech and Life Science.
https://trillimpact.com/ - Kind
Ventures Minority investments in early-stage companies in Europe and North America, primarily in Green Tech and Life Science.
https://www.trillimpact.com/ - Sectors
primarily in Green Tech and Life Science.
https://trillimpact.com/ - Sectors
primarily in Green Tech and Life Science.
https://www.trillimpact.com/
Status history
- 6 Nov 2026: Rolling (first extraction)
Is something out of date?
Suggest an editTakes 10 seconds
Something else wrong? Report an error.
Work at Trill Impact Ventures? Claim this profile to confirm what you invest in.